PharusDx Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $6.1M

  • Investors
  • 5

PharusDx General Information

Description

Developer of cancer screening tests designed for earlier detection and prevention of cancer. The company's technology utilizes RNA-based analysis and machine learning to extract insights from omics data, providing doctors with actionable information for clinical decisions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 7 Floor-7, Number 66, Shengyi 5th Road
  • Hsinchu County
  • Zhubei City, 302-61
  • Taiwan
+886 03
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Vertical(s)
Corporate Office
  • 7 Floor-7, Number 66, Shengyi 5th Road
  • Hsinchu County
  • Zhubei City, 302-61
  • Taiwan
+886 03

PharusDx Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PharusDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC 30-Apr-2025 $6.1M Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Early Stage VC 30-May-2024 Completed Generating Revenue
3. Accelerator/Incubator 30-May-2024 Completed Product In Beta Test
2. Early Stage VC (Series A1) 25-Jul-2022 $11M $11M Completed Product In Beta Test
1. Spin-Off 01-Jan-2022 Completed Product In Beta Test
To view PharusDx’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

PharusDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cancer screening tests designed for earlier detection and prevention of cancer. The company's technology ut
Biotechnology
Zhubei City, Taiwan
21 As of 2025

Madison, WI
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PharusDx Competitors (5)

One of PharusDx’s 5 competitors is Exact Sciences, a Formerly VC-backed company based in Madison, WI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Exact Sciences Formerly VC-backed Madison, WI
ClearNote Health Venture Capital-Backed San Diego, CA
Guardant Health Formerly VC-backed Palo Alto, CA
Immunovia Formerly VC-backed Lund, Sweden
MiRXES Formerly VC-backed Singapore, Singapore
You’re viewing 5 of 5 competitors. Get the full list »

PharusDx Patents

PharusDx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240287613-A1 Cancer early detection method using liquid biopsy Pending 24-Feb-2023
WO-2024174260-A1 Liquid biopsy-based early cancer screening method Inactive 24-Feb-2023
US-20220180973-A1 Early detection and prediction method of pan-cancer Pending 08-Dec-2020
WO-2022121960-A1 Method for predicting pan-cancer early screening Inactive 08-Dec-2020
EP-3904535-A1 Health risk assessment method Pending 24-Dec-2018 G16H50/30
To view PharusDx’s complete patent history, request access »

PharusDx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PharusDx Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Lee Family Office Family Office Minority
Larta Institute Accelerator/Incubator Minority
CK Hutchison Corporation Minority
CK Life Sciences Int'l., (Holdings) Corporation Minority
QuarkBio VC-Backed Company Minority
To view PharusDx’s complete investors history, request access »

PharusDx FAQs

  • When was PharusDx founded?

    PharusDx was founded in 2022.

  • Where is PharusDx headquartered?

    PharusDx is headquartered in Zhubei City, Taiwan.

  • What is the size of PharusDx?

    PharusDx has 21 total employees.

  • What industry is PharusDx in?

    PharusDx’s primary industry is Biotechnology.

  • Is PharusDx a private or public company?

    PharusDx is a Private company.

  • What is the current valuation of PharusDx?

    The current valuation of PharusDx is .

  • What is PharusDx’s current revenue?

    The current revenue for PharusDx is .

  • How much funding has PharusDx raised over time?

    PharusDx has raised $17.1M.

  • Who are PharusDx’s investors?

    Lee Family Office, Larta Institute, CK Hutchison, CK Life Sciences Int'l., (Holdings), and QuarkBio have invested in PharusDx.

  • Who are PharusDx’s competitors?

    Exact Sciences, ClearNote Health, Guardant Health, Immunovia, and MiRXES are competitors of PharusDx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process